Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1776 to 1800 of 2502

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Home care: delivering personal care and practical support to older people living in their own homesNG21
Thermogard XP for therapeutic hypothermia after cardiac arrestMIB37
i STAT CG4+ and CHEM8+ cartridges for point-of-care testing in the emergency departmentMIB38
Secondary prevention after a myocardial infarctionQS99
Coeliac disease: recognition, assessment and managementNG20
Hypertension in adultsQS28
Transcranial direct current stimulation (tDCS) for depressionIPG530
Preoperative high dose rate brachytherapy for rectal cancerIPG531
Vedolizumab for treating moderately to severely active Crohn's disease after prior therapyTA352
Bevacizumab for treating relapsed, platinum‑resistant epithelial ovarian, fallopian tube or primary peritoneal cancer (terminated appraisal)TA353
Edoxaban for treating and for preventing deep vein thrombosis and pulmonary embolismTA354
Antimicrobial stewardship: systems and processes for effective antimicrobial medicine useNG15
Infantile haemangioma: topical timololESUOM47
Visensia for early detection of deteriorating vital signs in adults in hospitalMIB36
Drug allergyQS97
Insertion of a double balloon catheter for induction of labour in pregnant women without previous caesarean sectionIPG528
Joint distraction for knee osteoarthritis without alignment correctionIPG529
Dyspepsia and gastro‑oesophageal reflux disease in adultsQS96
Naloxegol for treating opioid‑induced constipationTA345
Aflibercept for treating diabetic macular oedemaTA346
Everolimus for preventing organ rejection in liver transplantationTA348
Secukinumab for treating moderate to severe plaque psoriasisTA350
Cangrelor for reducing atherothrombotic events in people undergoing percutaneous coronary intervention or awaiting surgery requiring interruption of anti‑platelet therapy (terminated appraisal)TA351
Nintedanib for previously treated locally advanced, metastatic, or locally recurrent non‑small‑cell lung cancerTA347
Hypersexuality: fluoxetineESUOM46

Results per page

  1. 10
  2. 25
  3. 50
  4. All